With the granting of a further US patent, Capsulution has successfully extended its worldwide patent protection. The recently granted patent number US 7,101,575 is a basis patent for the production of nanocapsules according to the so-called LBL Technology®.
The LBL Technology® (Layer-by-Layer) is the source for a host of products and solutions within the life-science industry. Accordingly, the experts from Capsulution can endow the nanocapsules with special pharmaceutical, biochemical, electric, optical or magnetic properties and thus render them indispensable aids in many areas of life and science.
"The newly granted patent ensures our competitive advantage as one of the leading developers of nano and microcapsules in the field of modern life-science applications. We can pass this safeguard on to our customers who appreciate an outstanding and qualitatively high development performance from us," says Alexander Herrmann, CFO of Capsulution.
As well as nanocapsules, Capsulution also employs with numerous applications nanocomplexes which further extend the application possibilities due to their special release properties.
Capsulution owns the exclusive rights for the further development and worldwide marketing of the LBL Technology® which was originally developed by the Max Planck Society for the Advancement of Science.
Today, Capsulution especially focuses on applications in the field of drug delivery, medical devices and diagnostics, where tailor-made products are developed for industrial customers.
The LBL Technology® (Layer-by-Layer) is the source for a host of products and solutions within the life-science industry. Accordingly, the experts from Capsulution can endow the nanocapsules with special pharmaceutical, biochemical, electric, optical or magnetic properties and thus render them indispensable aids in many areas of life and science.
"The newly granted patent ensures our competitive advantage as one of the leading developers of nano and microcapsules in the field of modern life-science applications. We can pass this safeguard on to our customers who appreciate an outstanding and qualitatively high development performance from us," says Alexander Herrmann, CFO of Capsulution.
As well as nanocapsules, Capsulution also employs with numerous applications nanocomplexes which further extend the application possibilities due to their special release properties.
Capsulution owns the exclusive rights for the further development and worldwide marketing of the LBL Technology® which was originally developed by the Max Planck Society for the Advancement of Science.
Today, Capsulution especially focuses on applications in the field of drug delivery, medical devices and diagnostics, where tailor-made products are developed for industrial customers.
